These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7625856)

  • 1. Mast cells in melanocytic tumours.
    Schadendorf D; Kohlmus C; Gawlik C; Suter L; Czarnetzki BM
    Arch Dermatol Res; 1995; 287(5):452-6. PubMed ID: 7625856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cells in melanocytic skin lesions. An immunohistochemical and quantitative study.
    Dyduch G; Okoń K; Pescarini E
    Pol J Pathol; 2011 Sep; 62(3):139-44. PubMed ID: 22102069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
    Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
    J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased mast cell density in invasive melanoma.
    Duncan LM; Richards LA; Mihm MC
    J Cutan Pathol; 1998 Jan; 25(1):11-5. PubMed ID: 9508338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface microscopy of naevi and melanomas--clues to melanoma.
    Nilles M; Boedeker RH; Schill WB
    Br J Dermatol; 1994 Mar; 130(3):349-55. PubMed ID: 8148277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast cells and angiogenesis in canine melanomas: malignancy and clinicopathological factors.
    Mukaratirwa S; Chikafa L; Dliwayo R; Moyo N
    Vet Dermatol; 2006 Apr; 17(2):141-6. PubMed ID: 16515657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mast cell numbers in melanocytic naevi and cutaneous neurofibromas.
    Carr NJ; Warren AY
    J Clin Pathol; 1993 Jan; 46(1):86-7. PubMed ID: 8432898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Stromal Mast Cell Density in Canine Mammary Gland Tumours Predicts a Poor Prognosis.
    Ariyarathna H; Thomson N; Aberdein D; Munday JS
    J Comp Pathol; 2020 Feb; 175():29-38. PubMed ID: 32138840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nevus associated malignant melanomas--diagnostic validation and prognosis].
    Stadler R; Garbe C
    Hautarzt; 1991 Jul; 42(7):424-9. PubMed ID: 1938395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low numbers of tryptase+ and chymase+ mast cells associated with reduced survival and advanced tumor stage in melanoma.
    Siiskonen H; Poukka M; Bykachev A; Tyynelä-Korhonen K; Sironen R; Pasonen-Seppänen S; Harvima IT
    Melanoma Res; 2015 Dec; 25(6):479-85. PubMed ID: 26317168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of endoglin in human melanocytic lesions.
    Dawn G; MacKie RM
    Clin Exp Dermatol; 2002 Mar; 27(2):153-6. PubMed ID: 11952710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VS38 immunostaining in melanocytic lesions.
    Shanks JH; Banerjee SS
    J Clin Pathol; 1996 Mar; 49(3):205-7. PubMed ID: 8675729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of intercellular adhesion molecule-1 (ICAM-1) in benign naevi and malignant melanomas.
    Hansen NL; Ralfkiaer E; Hou-Jensen K; Thomsen K; Drzewiecki KT; Rothlein R; Vejlsgaard GL
    Acta Derm Venereol; 1991; 71(1):48-51. PubMed ID: 1676215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
    Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
    Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ultrastructural features of benign and malignant lesions of a melanocytic nature].
    Filippova NA; Shetinina LN
    Arkh Patol; 1992; 54(2):39-45. PubMed ID: 1524501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced expression of actin-binding proteins, h-caldesmon and calponin h1, in the vascular smooth muscle inside melanoma lesions: an adverse prognostic factor for malignant melanoma.
    Koganehira Y; Takeoka M; Ehara T; Sasaki K; Murata H; Saida T; Taniguchi S
    Br J Dermatol; 2003 May; 148(5):971-80. PubMed ID: 12786828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution laser Doppler perfusion imaging aids in differentiating between benign and malignant melanocytic skin tumours.
    Stücker M; Esser M; Hoffmann M; Memmel U; Hirschmüller A; von Bormann C; Hoffmann K; Altmeyer P
    Acta Derm Venereol; 2002; 82(1):25-9. PubMed ID: 12013193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis of the S100A1, S100B, CD44 and Bcl-2 antigens and the rate of cell proliferation assessed by Ki-67 antibody in benign and malignant melanocytic tumours.
    Sviatoha V; Tani E; Kleina R; Sperga M; Skoog L
    Melanoma Res; 2010 Apr; 20(2):118-25. PubMed ID: 20042890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equine skin tumours in 20 horses resembling three variants of human melanocytic naevi.
    Schöniger S; Summers BA
    Vet Dermatol; 2009 Jun; 20(3):165-73. PubMed ID: 19374725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moesin and CD44 expression in cutaneous melanocytic tumours.
    Ichikawa T; Masumoto J; Kaneko M; Saida T; Sagara J; Taniguchi S
    Br J Dermatol; 1998 May; 138(5):763-8. PubMed ID: 9666819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.